BioCryst Pharmaceuticals logo
BioCryst Pharmaceuticals BCRX
$ 7.6 1.4%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

BioCryst Pharmaceuticals Long Term Debt Current 2011-2024 | BCRX

Annual Long Term Debt Current BioCryst Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.06 M 1.52 M 1.82 M - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.82 M 1.06 M 1.46 M